Supplementary materials Web view115.Gonzalez Ibarra FP, Garcia Tizoc E, Rojo Jimenez AG, Aguila...
26
Supplementary materials Supplementary file I Search strategy Pubmed, 29-04-2020 (("Lupus Erythematosus, Systemic"[mesh] OR "systemic lupus erythematosus"[tw] OR "SLE"[tw] OR "NPSLE"[tw] OR "Lupus"[tw]) AND ("Myelitis, Transverse"[Mesh] OR "myelitis transversa"[tw] OR "myelitis transverse"[tw] OR "transverse myelitis"[tw] OR "Demyelinative Myelitis"[tw] OR "Necrotising Myelitis"[tw] OR "Necrotizing Myelitis"[tw] OR "Myelitis"[mesh] OR "myelitis"[tw] OR "myelopathy"[tw] OR myelopath*[tw]) NOT ("Animals"[mesh] NOT "Humans"[mesh]) AND (english[la] OR dutch[la] OR german[la])) 1 2 3 4 5 6 7 8 9 10 11
Supplementary materials Web view115.Gonzalez Ibarra FP, Garcia Tizoc E, Rojo Jimenez AG, Aguila Gastelum CL, Jorge Alberto ZL, Maradiaga Cecena MA. Acute transverse myelitis in systemic
Search strategy Pubmed, 29-04-2020
(("Lupus Erythematosus, Systemic"[mesh] OR "systemic lupus
erythematosus"[tw] OR "SLE"[tw] OR "NPSLE"[tw] OR "Lupus"[tw]) AND
("Myelitis, Transverse"[Mesh] OR "myelitis transversa"[tw] OR
"myelitis transverse"[tw] OR "transverse myelitis"[tw] OR
"Demyelinative Myelitis"[tw] OR "Necrotising Myelitis"[tw] OR
"Necrotizing Myelitis"[tw] OR "Myelitis"[mesh] OR "myelitis"[tw] OR
"myelopathy"[tw] OR myelopath*[tw]) NOT ("Animals"[mesh] NOT
"Humans"[mesh]) AND (english[la] OR dutch[la] OR german[la]))
Supplementary figure 1 Literature review, article selection
process
Supplementary file II
Quality assessment
Risk of bias was considered high in case-reports and case-series,
as selective reporting is present by default and clinical outcome
is not predefined. Risk of bias varied among the observational
studies: the majority of studies identified patients with TM by
retrospective chart review of SLE patients in a given time period
in one hospital. Some articles reported the total amount of
patients identified and included, showing the most transparency
about the process selection. 37, 41, 44, 45, 48, 50, 52 Other
studies did not mention how many patients were originally
identified 1, 24, 40, 46, 47,51-52 and two studies collected data
by inviting clinicians to participate and reporting cases, leading
to a higher risk of bias. 23, 49 Clinical outcome was predefined in
most studies, using validated scales such as the American Spinal
Injury Association scale for spinal cord injury. In other studies,
outcome of individual participants was described in great detail
and therefore the decision rules defined regarding clinical outcome
in the Method sections could be applied easily. 25,27,32 Only one
study did not have a clear definition what was considered
recovery/improvement in patients with TM. 28
Supplementary file III
Supplementary table 1 Data extracted from case-reports and
case-series, ordered chronologically
Ref
Sex
Age
(yrs)
SLEa
Onset
(yrs)b
sMRI
F
51
F
40
F
23
NA
HD: +/-
Notes: + = present or abnormal; - = absent or normal; NA = not
available. a Diagnosis of SLE according to ACR criteria b SLE
duration in years c Outcome: ++ = full recovery; + = nearly
complete recovery; +/- = partial improvement; - = no improvement;
-- = death
Abbreviations: CSF, cerebrospinal fluid; HD, during hospital stay
or at hospital discharge; OCB, oligoclonal bands; sMRI, MRI of the
spinal cord; ST, short term, between hospital discharge – 6 months;
LT, long term (longer than 6 months); WBC, white blood cells
V: References, part II
53. Kenik JG, Krohn K, Kelly RB, Bierman M, Hammeke MD, Hurley JA.
Transverse myelitis and optic neuritis in systemic lupus
erythematosus: a case report with magnetic resonance imaging
findings. Arthritis Rheum. 1987;30(8):947-950.
54. Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Klippel JH,
Balow JE. Acute transverse myelitis in systemic lupus
erythematosus: magnetic resonance imaging and review of the
literature. J Rheumatol. 1990;17(1):89-92.
55. Moriwaka F, Tashiro K, Fukazawa T, et al. A case of systemic
lupus erythematosus--its clinical and MRI resemblance to multiple
sclerosis. Jpn J Psychiatry Neurol. 1990;44(3):601-605.
56. Berlanga B, Ramon Rubio F, Moga I, Pac V. Response to
intravenous cyclophosphamide treatment in lupus myelopathy [5].
Journal of Rheumatology. 1992;19(5):829-830.
57. Nived O, Sturfelt G, Ryberg B. Two UV-induced episodes of
myelitis in a patient with systemic lupus erythematosus. J Intern
Med. 1992;232(5):461-463.
58. Simeon-Aznar CP, Tolosa-Vilella C, Cuenca-Luque R,
Jordana-Comajuncosa R, Ordi-Ros J, Bosch-Gil JA. Transverse
myelitis in systemic lupus erythematosus: two cases with magnetic
resonance imaging. Br J Rheumatol. 1992;31(8):555-558.
59. Tola MR, Casetta I, Granieri E, Caniatti LM, Monetti VC,
Pascarella R. Systemic lupus erythematosus related recurrent
transverse myelitis in a patient with myasthenia gravis and
multiple sclerosis. Eur Neurol. 1996;36(5):327-328.
60. Holtas S, Basibuyuk N, Fredriksson K. MRI IN ACUTE TRANSVERSE
MYELOPATHY. Neuroradiology. 1993;35(3):221-226.
61. Klaiman MD, Miller SD. Transverse myelitis complicating
systemic lupus erythematosus: treatment including
hydroxychloroquine. Case report. Am J Phys Med Rehabil.
1993;72(3):158-161.
62. Provenzale JM, Barboriak DP, Gaensler EH, Robertson RL, Mercer
B. Lupus-related myelitis: serial MR findings. AJNR Am J
Neuroradiol. 1994;15(10):1911-1917.
63. Stahl HD, Ettlin TH, Plohmann A, et al. Central nervous system
lupus: concomitant occurrence of myelopathy and cognitive
dysfunction. Clin Rheumatol. 1994;13(2):273-279.
64. Lopez Dupla M, Khamashta MA, Sanchez AD, Ingles FP, Uriol PL,
Aguado AG. Transverse myelitis as a first manifestation of systemic
lupus erythematosus: a case report. Lupus. 1995;4(3):239-242.
65. Oriordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF,
and MRI findings in Devic's neuromyelitis optica. Journal of
Neurology Neurosurgery and Psychiatry. 1996;60(4):382-387.
66. Kuzma BB, Goodman JM. Spinal cord swelling and brain lesions in
lupus myelitis. Surg Neurol. 1997;48(2):200-202.
67. Radis CD, Callis KP. Systemic lupus erythematosus with
membranous glomerulonephritis and transverse myelitis associated
with anabolic steroid use. Arthritis Rheum.
1997;40(10):1899-1902.
68. Habr F, Wu B. Acute transverse myelitis in systemic lupus
erythematosus: a case of rapid diagnosis and complete recovery.
Conn Med. 1998;62(7):387-390.
69. Inslicht DV, Stein AB, Pomerantz F, Ragnarsson KT. Three women
with lupus transverse myelitis: case reports and differential
diagnosis. Arch Phys Med Rehabil. 1998;79(4):456-459.
70. Schantz V, Oestergaard LL, Junker P. Shrinking spinal cord
following transverse myelopathy in a patient with systemic lupus
erythematosus and the phospholipid antibody syndrome. J Rheumatol.
1998;25(7):1425-1428.
71. Rodriguez AS, Oterino JA, Hernandez PA. Lupus myelitis. Arch
Intern Med. 1998;158(20):2267-2268.
72. Deodhar AA, Hochenedel T, Bennett RM. Longitudinal involvement
of the spinal cord in a patient with lupus related transverse
myelitis. J Rheumatol. 1999;26(2):446-449.
73. Huang TY, Sileo DR, Huang JT, Postel GC, Abaskaron M, Aaron JO.
MR imaging of acute transverse myelitis. J Ky Med Assoc.
1999;97(4):165-167.
74. Margaux J, Hayem G, Meyer O, Kahn MF. Systemic lupus
erythematosus with optical neuromyelitis (Devic's syndrome). A case
with a 35-year follow-up. Rev Rhum Engl Ed.
1999;66(2):102-105.
75. Mok CC, Lee KW, Wong RW, Lau CS. Acute lupus myelitis affecting
the clonus medullaris. Clin Exp Rheumatol.
1999;17(1):123-124.
76. Neumann-Andersen G, Lindgren S. Involvement of the entire
spinal cord and medulla oblongata in acute catastrophic-onset
transverse myelitis in SLE. Clin Rheumatol.
2000;19(2):156-160.
77. Trysberg E, Lindgren I, Tarkowski A. Autologous stem cell
transplantation in a case of treatment resistant central nervous
system lupus. Ann Rheum Dis. 2000;59(3):236-238.
78. Tellez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO,
Davila-Maldonado L. Longitudinal myelitis associated with systemic
lupus erythematosus: clinical features and magnetic resonance
imaging of six cases. Lupus. 2001;10(12):851-856.
79. Yazawa S, Kawasaki S, Ohi T, et al. Development of severe
longitudinal atrophy of thoracic spinal cord following
lupus-related myelitis. Intern Med. 2001;40(4):353-357.
80. Gibbs AN, Moroney J, Foley-Nolan D, O'Connell PG. Neuromyelitis
optica (Devic's syndrome) in systemic lupus erythematosus: a case
report. Rheumatology (Oxford). 2002;41(4):470-471.
81. Kimura KY, Seino Y, Hirayama Y, et al. Systemic lupus
erythematosus related transverse myelitis presenting longitudinal
involvement of the spinal cord. Intern Med.
2002;41(2):156-160.
82. Drake WP, Byrd VM, Olsen NJ. Reactivation of systemic lupus
erythematosus after initiation of highly active antiretroviral
therapy for acquired immunodeficiency syndrome. J Clin Rheumatol.
2003;9(3):176-180.
83. Leung FK, Fortin PR. Intravenous cyclophosphamide and high dose
corticosteroids improve MRI lesions in demyelinating syndrome in
systemic lupus erythematosus. Journal of Rheumatology.
2003;30(8):1871-1873.
84. Suralkar SS, Bichile LS, Sonawale AS, Rajyadhyaksha AG, Kothari
C. Myelitis as a presenting feature of systemic lupus
erythromatosus. J Assoc Physicians India. 2003;51:62-63.
85. Charakidas A, Brouzas D, Perraki A, Moschos M. Neuromyelitis
optica (Devic's disease) in a case of systemic lupus erythematosus
with antiphospholipid antibodies: Is there a role for
anticoagulants? Neuro-Ophthalmology. 2004;28(4):179-181.
86. Krishnan AV, Halmagyi GM. Acute transverse myelitis in SLE.
Neurology. 2004;62(11):2087-.
87. Lehnhardt FG, Impekoven P, Rubbert A, et al. Recurrent
longitudinal myelitis as primary manifestation of SLE. Neurology.
2004;63(10):1976.
88. Mok CC, Mak A, Tsui EYK. Shrinking central nervous system in
systemic lupus erythematosus. Annals of the Rheumatic Diseases.
2004;63(5):603-604.
89. Moranne O, Hachulla E, Valat AS, Sotoares G, Pagniez D,
Boulanger E. Longitudinal myelitis in a pregnant patient with SLE.
Am J Med. 2004;116(5):355-357.
90. dos Santos VM, Correia Garcia E, Leao Rabelo F, Menezes Haase
Lobo GE, Santos Damasceno MA. Transverse myelitis and chronic
urticaria in systemic lupus erythematosus. Case report. Rev Med
Chil. 2005;133(2):209-213.
91. Ferreira S, Marques P, Carneiro E, D'Cruz D, Gama G. Devic's
syndrome in systemic lupus erythematosus and probable
antiphospholipid syndrome. Rheumatology (Oxford).
2005;44(5):693-695.
92. Fioravanti A, Vallone IM, Cantarini L, Malandrini A, Cerase A.
Long-term follow-up of lupus-related subacute myelopathy treated by
plasmapheresis and pulse cyclophosphamide. Clin Exp Rheumatol.
2005;23(5):734.
93. Hagiwara N, Toyoda K, Uwatoko T, Yasumori K, Ibayashi S, Okada
Y. Successful high dose glucocorticoid treatment for subacute
neuromyelitis optica with systemic lupus erythematosus. Intern Med.
2005;44(9):998-1001.
94. Rheu CW, Lee SI, Yoo WH. A catastrophic-onset longitudinal
myelitis accompanied by bilateral internuclear ophthalmoplegia in a
patient with systemic lupus erythematosus. J Korean Med Sci.
2005;20(6):1085-1088.
95. Yago T, Tateishi M, Ichikawa N, et al. A case of systemic lupus
erythematosus presenting transverse myelitis after an episode of
meningitis. Mod Rheumatol. 2005;15(5):367-370.
96. Yamanaka F, Migita K, Ichinose K, et al. Catastrophic
transverse myelitis in a patient with systemic lupus erythematosus.
Mod Rheumatol. 2005;15(2):130-133.
97. Armstrong DJ, McCarron MT, Wright GD. SLE-associated transverse
myelitis successfully treated with Rituximab (anti-CD20 monoclonal
antibody). Rheumatol Int. 2006;26(8):771-772.
98. Lehnhardt FG, Scheid C, Holtik U, et al. Autologous blood stem
cell transplantation in refractory systemic lupus erythematodes
with recurrent longitudinal myelitis and cerebral infarction.
Lupus. 2006;15(4):240-243.
99. Birnbaum J, Kerr D. Devic's syndrome in a woman with systemic
lupus erythematosus: diagnostic and therapeutic implications of
testing for the neuromyelitis optica IgG autoantibody. Arthritis
Rheum. 2007;57(2):347-351.
100. Heinlein AC, Gertner E. Marked inflammation in catastrophic
longitudinal myelitis associated with systemic lupus erythematosus.
Lupus. 2007;16(10):823-826.
101. Ilniczky S, Kamondi A, Aranyi Z, et al. Simultaneous central
and peripheral nervous system involvement in systemic lupus
erythematosus. Ideggyogy Sz. 2007;60(9-10):398-402.
102. Tomietto P, D'Agostini S, Annese V, De Vita S, Ferraccioli G.
Mycophenolate mofetil and intravenous dexamethasone in the
treatment of persistent lupus myelitis. J Rheumatol.
2007;34(3):588-591.
103. Touma Z, Atweh SF, Kibbi L, Arayssi T. Longitudinal myelitis
in patient with systemic lupus erythematosus, homozygous
prothrombin G20210A and heterozygous MTHFR 677T. Lupus.
2007;16(7):517-520.
104. Birnbaum J, Kerr D. Optic neuritis and recurrent myelitis in a
woman with systemic lupus erythematosus. Nat Clin Pract Rheumatol.
2008;4(7):381-386.
105. Mehta LR, Samuelsson MK, Kleiner AK, et al. Neuromyelitis
optica spectrum disorder in a patient with systemic lupus
erythematosus and anti-phospholipid antibody syndrome. Mult Scler.
2008;14(3):425-427.
106. Mok CC, To CH, Mak A, Poon WL. Immunoablative cyclophosphamide
for refractory lupus-related neuromyelitis optica. J Rheumatol.
2008;35(1):172-174.
107. Orzechowski NM, Michet CJ, Jr. Longitudinal myelitis. Mayo
Clin Proc. 2008;83(3):350.
108. Almoallim H, Bukhari M, Alwafi L, Wali G. Transverse myelitis
as a presenting feature of late onset systemic lupus erythematosus.
Ann Saudi Med. 2009;29(2):156-157.
109. Ammouri W, Mezalek ZT, Harmouche H, Aouni M, Adnaoui M,
Maaouni A. Myelitis complicating systemic lupus erythematosus:
successfully treated with corticosteroids and cyclophosphamide.
South Med J. 2009;102(7):744-745.
110. Celebisoy N, Gulec F, Bayrakci A, Yargucu F. Longitudinal
myelitis as the first manifestation of systemic lupus
erythematosus. Journal of Neurological Sciences.
2009;26(4):492-494.
111. Karim S, Majithia V. Devic's syndrome as initial presentation
of systemic lupus erythematosus. Am J Med Sci.
2009;338(3):245-247.
112. Mottaghi P, Ashtari F, Karimzadeh H, Seidbonakdar Z, Karimifar
M, Salesi M. Devic's syndrome concomitant with nephritis in a young
woman. Clin Rheumatol. 2009;28(10):1239-1240.
113. Mula M, Bolamperti L, Varrasi C, et al. SLE-related
longitudinal myelitis with favorable outcome. Can J Neurol Sci.
2009;36(3):393-397.
114. Nasir S, Kerr DA, Birnbaum J. Nineteen episodes of recurrent
myelitis in a woman with neuromyelitis optica and systemic lupus
erythematosus. Arch Neurol. 2009;66(9):1160-1163.
115. Gonzalez Ibarra FP, Garcia Tizoc E, Rojo Jimenez AG, Aguila
Gastelum CL, Jorge Alberto ZL, Maradiaga Cecena MA. Acute
transverse myelitis in systemic lupus erythematosus: Report of a
case. Critical Care and Shock. 2010;13(1):18-21.
116. Katchanov J, Grassl W, Wenzel R. Longitudinal brainstem
involvement in systemic lupus erythematosus. Lupus.
2010;19(3):335-336.
117. Marcel C, Kremer S, Jeantroux J, Blanc F, Dietemann JL, De
Seze J. Diffusion-weighted imaging in noncompressive myelopathies:
a 33-patient prospective study. J Neurol.
2010;257(9):1438-1445.
118. Pellkofer HL, Hohlfeld R, Kuempfel T. Thirty-one episodes of
myelitis and optic neuritis in a woman with neuromyelitis optica
and systemic lupus erythematosus. Arch Neurol. 2010;67(6):779-780;
author reply 780.
119. Richard Mornas A, Thomas T, Pallot Prades B, Chopin F, Raoux
D. Longitudinal myelitis in a patient with systemic lupus
erythematosus. Joint Bone Spine. 2010;77(2):181-183.
120. Zotos P, Poularas J, Karakitsos D, Karabinis A. Lupus related
longitudinal myelitis. J Rheumatol. 2010;37(8):1776.
121. Deme SM, Jianu DC, Calomfirescu SK. A case repost of chronic
urticaria in systemic lupus erythematosus associating transverse
myelitis. Romanian Journal of Neurology/ Revista Romana de
Neurologie. 2011;10(1):52-58.
122. Kayim Yildiz O, Balaban H, Senel S. Anti-aquaporin-4 antibody
positive relapsing neuromyelitis optica in a patient with systemic
lupus erythematosus. Journal of Neurological Sciences.
2011;28(3):376-379.
123. Polgar A, Rozsa C, Muller V, Matolcsi J, Poor G, Kiss EV.
Devic's syndrome and SLE: challenges in diagnosis and therapeutic
possibilities based on two overlapping cases. Autoimmun Rev.
2011;10(3):171-174.
124. Ye Y, Qian J, Gu Y, Chen X, Ye S. Rituximab in the treatment
of severe lupus myelopathy. Clin Rheumatol.
2011;30(7):981-986.
125. Hernando Rubio I, Belzunegui Otano J, Maiz Alonso O, Alvarez
Rodriguez B. Transverse myelitis and bilateral optic neuritis in a
patient with systemic lupus erythematosus. Reumatol Clin.
2012;8(5):298-299.
126. Katsumata Y, Kawachi I, Kawaguchi Y, et al. Semiquantitative
measurement of aquaporin-4 antibodies as a possible surrogate
marker of neuromyelitis optica spectrum disorders with systemic
autoimmune diseases. Mod Rheumatol. 2012;22(5):676-684.
127. White C, Leonard B, Patel A. Longitudinally extensive
transverse myelitis: a catastrophic presentation of a flare-up of
systemic lupus erythematosus. Cmaj. 2012;184(3):E197-200.
128. Gude DC, Chennamsetty S, Bansal DP, Jha R. Transverse myelitis
in antiphospholipid antibody negative systemic lupus erythematosus.
J Indian Med Assoc. 2013;111(6):406-407.
129. Huang LK, Chung CC, Chen BZ, Chi NF, Hu CJ. Systemic lupus
erythematosus presented as extensive longitudinal myelitis. Acta
Neurol Taiwan. 2013;22(2):67-71.
130. Jiang DX, Liao Y, Bai YJ. Successful treatment for
neuromyelitis optica with systemic lupus erythematosus. Chin Med J
(Engl). 2013;126(20):3996.
131. Yachoui R, Kolasinski SL, Han BK. Intractable vomiting as an
initial presentation of lupus-related neuromyelitis optica. J Clin
Rheumatol. 2013;19(3):154-155.
132. Zavada J, Nytrova P, Wandinger KP, et al. Seroprevalence and
specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients
with neuropsychiatric systemic lupus erythematosus. Rheumatol Int.
2013;33(1):259-263.
133. Adawi M, Bisharat B, Bowirrat A. Systemic Lupus Erythematosus
(SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease):
Clinic-Pathological Report and Review of the Literature. Clin Med
Insights Case Rep. 2014;7:41-47.
134. Kim SY, Yoon TS, Suh JH. Concomitant occurrence of cervical
myelopathy, cerebral infarction, and peripheral neuropathy in
systemic lupus erythematosus: a case report. Ann Rehabil Med.
2014;38(2):263-268.
135. Loster-Niewinska A, Chojdak-Lukasiewicz J, Sasiadek M,
Szmyrka-Kaczmarek M, Paradowski B. Acute transverse myelitis as the
first clinical manifestation of systemic lupus erythematosus.
Neurol India. 2014;62(6):712-713.
136. Modjinou D, Gurin L, Chhabra A, Mikolaenko I, Lydon E, Smiles
S. A case of systemic lupus erythematosus associated with
longitudinal extensive transverse myelitis, cerebral neutrophilic
vasculitis, and cerebritis. Bull Hosp Jt Dis (2013).
2014;72(4):294-300.
137. Guerrero C, Cabezas-Quintario MA, Algora A, Martin A.
Longitudinally extensive transverse myelitis with neuro-lymphatic
protein expressionin systemic lupus erithematosus patient. An
autopsy case report. Revista Espanola de Patologia.
2015;48(4):217-221.
138. Menor Almagro R, Ruiz Tudela Mdel M, Giron Ubeda J, Cardiel
Rios MH, Perez Venegas JJ, Garcia Guijo C. Myelitis transverse in
Sjogren's syndrome and systemic lupus erythematosus: presentation
of 3 cases. Reumatol Clin. 2015;11(1):41-44.
139. Nardone R, Fitzgerald RT, Bailey A, Zuccoli G. Longitudinally
extensive transverse myelitis in systemic lupus erythematosus: case
report and review of the literature. Clin Neurol Neurosurg.
2015;129:57-61.
140. Takei K, Sato M, Nakamura M, Shimizu H. Longitudinally
extensive transverse myelitis with anti-NMDA receptor antibodies
during a systemic lupus erythematosus flare-up. BMJ Case Rep.
2015;2015.
141. Kovacs KT, Kalluri SR, Boza-Serrano A, et al. Change in
autoantibody and cytokine responses during the evolution of
neuromyelitis optica in patients with systemic lupus erythematosus:
A preliminary study. Mult Scler. 2016;22(9):1192-1201.
142. Srivastava A, Kundu BK, Singh DK. Concomitant Guillain Barre
Syndrome and Transverse Myelitis as Initial Neuropsychiatric
Manifestation in a Case of Lupus: A Diagnostic Quandary. Case Rep
Rheumatol. 2016;2016:5827860.
143. Tono T, Nagai T, Hoshiyama T, et al. Transverse myelitis
extended to disseminated encephalitis in systemic lupus
erythematosus: Histological evidence for vasculitis. Mod Rheumatol.
2016;26(6):958-962.
144. Chessa E, Piga M, Floris A, Mathieu A, Cauli A. Demyelinating
syndrome in SLE: review of different disease subtypes and report of
a case series. Reumatismo. 2017;69(4):175-183.
145. Deveza LM, Neves EF, Seguro LP, Pereira SL, Bonfa E, Pasoto
SG. Longitudinal Extensive Transverse Myelitis and Central Diabetes
Insipidus: A Severe Flare of Systemic Lupus Erythematosus. J Clin
Rheumatol. 2017;23(2):122-124.
146. Mansoor AC, Jemshad A, Musambil M. Systemic lupus
erythematosus presenting as rectal ulcer and longitudinal
myelopathy. Int J Rheum Dis. 2017;20(11):1818-1820.
147. Oiwa H, Yamabe T, Kawashima M, et al. A report of three cases
with lupus myelitis. Eur J Rheumatol. 2017;4(2):148-150.
148. Aguirre-Villarreal D, Whittall LP, Fragoso-Loyo H, Cantu-Brito
C, Crispin JC, Valdes-Ferrer SI. Intrathecal formation of
anticardiolipin antibodies in a patient with SLE-related relapsing
longitudinal myelitis: a possible pathogenic connection. Lupus.
2018;27(14):2292-2295.
149. Asgari N, Jarius S, Laustrup H, et al.
Aquaporin-4-autoimmunity in patients with systemic lupus
erythematosus: A predominantly population-based study. Mult Scler.
2018;24(3):331-339.
150. Bozic K, Komatina N, Petronijevic M, Knezevic B, Kostic D,
Stefanovic D. Neuromyelitis optica spectrum disorder in patient
with systemic lupus erythematosus - Our experience. Vojnosanitetski
Pregled. 2018;75(1):104-107.
151. Duarte AC, Sousa S, Nunes T, Cordeiro A, Goncalves P.
Intravenous human immunoglobulin for the treatment of severe
longitudinal extensive transverse myelitis associated with systemic
lupus erythematous. Acta Reumatol Port. 2018;43(2):154-155.
152. Furtado I, Pinheiro G, Campar A, Mendonca T. Association of
severe and therapy-refractory systemic lupus erythematosus and
neuromyelitis optica: a management challenge. BMJ Case Rep.
2018;2018.
153. Raciborska DD, Noyce AJ, Pyne D, Turner BP. Lupus myelopathy.
Pract Neurol. 2018;18(1):66-69.
154. Patterson SL, Jafri K, Narvid JA, Margaretten M. A Young Woman
With Sudden Urinary Retention and Sensory Deficits. Arthritis Care
Res (Hoboken). 2018;70(4):635-642.
155. Schattner A, Voichanski S, Uliel L. SLE presenting as
demyelinative autoimmune visual loss. BMJ Case Rep.
2018;2018.
156. Shidahara K, Hayashi K, Sada KE, et al. Refractory
neuromyelitis optica spectrum disorder in systemic lupus
erythematosus successfully treated with rituximab. Lupus.
2018;27(8):1374-1377.
157. Zahid AS, Mubashir A, Mirza SA, Naqvi IH, Talib A. Systemic
Lupus Erythematosus Presenting as Longitudinally Extensive
Transverse Myelitis and Nephritis: A Case Report. Cureus.
2018;10(4):e2402.
158. Chaneva O, Viteva E, Trenova A, et al. Neuromyelitis Optica
and Systemic Lupus Erythematosus Association - the Chicken or the
Egg Dilemma: a Case Repor. Folia Med (Plovdiv).
2019;61(4):639-642.
159. Jackson SD, Wiering BA, Bentley IA, Herrmann AA, Hanson LR.
From A to D: A Unique Case Report of Recovery After Longitudinal
Myelitis Related to Lupus. Am J Phys Med Rehabil.
2019;98(10):e119-e122.
160. Jha VK, Sharda V, Rajkamal T, Bhatt TC. Pruritus as Unusual
Manifestation of Lupus Myelopathy. J Assoc Physicians India.
2019;67(3):95-97.
161. Lavandier N, Bonnan M, Carra-Dalliere C, et al. First clinical
inflammatory demyelinating events of the central nervous system in
a population aged over 70 years: A multicentre study. Mult Scler
Relat Disord. 2019;28:309-312.
162. Martin-Nares E, Hernandez-Molina G, Fragoso-Loyo H.
Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and
systemic autoimmune diseases overlap syndrome: a single-center
experience. Lupus. 2019;28(11):1302-1311.
163. Martins N, Antunes AP, Macieira C. Neuromyelitis Optica
Spectrum Disorder in a Patient With Systemic Lupus Erythematosus. J
Clin Rheumatol. 2019;25(4):38-40.
164. Mehmood T, Munir I, Abduraimova M, Ramirez MA, Paghdal S,
McFarlane IM. Longitudinally Extensive Transverse Myelitis
Associated With Systemic Lupus Erythematosus: A Case Report and
Literature Review. Am J Med Case Rep. 2019;7(10):244-249.
165. Seyedali S, Alpert DR. Longitudinal extensive transverse
myelitis: a rare neurological complication of systemic lupus
erythematosus. BMJ Case Rep. 2019;12(4).
166. Thabah MM, D S, Pranov R, Moulitej MMV, Ramesh A, Kadhiravan
T. Neuromyelitis optica spectrum disorder and systemic lupus
erythematosus. Lupus. 2019;28(14):1722-1726.
167. Vassallo J. Area Postrema Syndrome Secondary to Lupus
Neuroinflammation. J Pediatr Ophthalmol Strabismus.
2019;56(5):340.
168. Iftikhar S, Mahmood A, Hashmat M. Neuromyelitis Optica as an
Initial Presentation of Systemic Lupus Erythematosus in a Young
Male. J Coll Physicians Surg Pak. 2020;30(3):321-323.
169. Prabhat N, Chakravarty K, Pattnaik SN, Takkar A, Ray S, Lal V.
Systemic lupus erythematosus with autoimmune neurological
manifestations in a carrier of chronic granulomatous disease - a
rare presentation. J Neuroimmunol. 2020;343:577229.
8